Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jupiter

Rank: Treasurer [?]

Points: 619 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

in response to

Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

KOO-KOO2

posted on Mar 24, 2020 05:00PM

Koo,

Gordon et al. identified BRD2/4 as a binding partner of viral protein E.

Resverlogix states that Apabetalone was shown to disrupt this interaction.

Jupe

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply